ID
28269
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/7/17 12/7/17 -
- 1/1/18 1/1/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
January 1, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Radiotherapy GOAL Trial B-cell Lymphoma NCT02499003
Radiotherapy GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Radiotherapy
Alias
- UMLS CUI-1
- C1522449
Description
Radiotherapy number
Data type
integer
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0449788
Description
N = Node, O = Organ
Data type
integer
Alias
- UMLS CUI [1,1]
- C0475264
- UMLS CUI [1,2]
- C1522449
Description
specification
Data type
text
Alias
- UMLS CUI [1]
- C2348235
Description
Total dose radiotherapy
Data type
float
Measurement units
- Gy
Alias
- UMLS CUI [1]
- C2919490
Description
Start date
Data type
date
Alias
- UMLS CUI [1]
- C0808070
Description
End date
Data type
date
Alias
- UMLS CUI [1]
- C0806020
Description
Best response
Data type
integer
Alias
- UMLS CUI [1]
- C2986560
Similar models
Radiotherapy GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
C0449788 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
C0806692 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C1547326 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)